Geode Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.3M Buy
775,493
+24,995
+3% +$203K ﹤0.01% 2608
2025
Q1
$5.29M Buy
750,498
+64,752
+9% +$456K ﹤0.01% 2624
2024
Q4
$5.1M Buy
685,746
+88,061
+15% +$655K ﹤0.01% 2741
2024
Q3
$2.95M Buy
597,685
+55,703
+10% +$275K ﹤0.01% 3003
2024
Q2
$2.78M Buy
541,982
+255,020
+89% +$1.31M ﹤0.01% 3016
2024
Q1
$1.52M Buy
286,962
+1,877
+0.7% +$9.97K ﹤0.01% 3217
2023
Q4
$1.77M Buy
285,085
+9,175
+3% +$56.8K ﹤0.01% 3152
2023
Q3
$2.08M Sell
275,910
-10,667
-4% -$80.5K ﹤0.01% 3066
2023
Q2
$2.77M Sell
286,577
-205,813
-42% -$1.99M ﹤0.01% 3005
2023
Q1
$1.86M Buy
492,390
+27,175
+6% +$103K ﹤0.01% 3063
2022
Q4
$3.01M Buy
465,215
+569
+0.1% +$3.69K ﹤0.01% 2898
2022
Q3
$4.13M Sell
464,646
-13,784
-3% -$123K ﹤0.01% 2770
2022
Q2
$4.77M Buy
478,430
+6,945
+1% +$69.2K ﹤0.01% 2724
2022
Q1
$5.46M Buy
471,485
+10,404
+2% +$120K ﹤0.01% 2750
2021
Q4
$5.12M Buy
461,081
+10,287
+2% +$114K ﹤0.01% 2888
2021
Q3
$4.16M Sell
450,794
-288
-0.1% -$2.66K ﹤0.01% 3018
2021
Q2
$5.07M Buy
451,082
+28,122
+7% +$316K ﹤0.01% 2901
2021
Q1
$4.48M Buy
422,960
+6,778
+2% +$71.8K ﹤0.01% 2847
2020
Q4
$4.52M Sell
416,182
-14,434
-3% -$157K ﹤0.01% 2657
2020
Q3
$4.19M Buy
430,616
+9,449
+2% +$91.8K ﹤0.01% 2504
2020
Q2
$3.35M Buy
421,167
+3,379
+0.8% +$26.9K ﹤0.01% 2548
2020
Q1
$3.63M Buy
417,788
+44,419
+12% +$386K ﹤0.01% 2335
2019
Q4
$4.22M Buy
373,369
+11,710
+3% +$132K ﹤0.01% 2563
2019
Q3
$3.93M Buy
361,659
+13,036
+4% +$142K ﹤0.01% 2527
2019
Q2
$3.27M Buy
348,623
+15,099
+5% +$141K ﹤0.01% 2641
2019
Q1
$4.1M Buy
333,524
+55,413
+20% +$680K ﹤0.01% 2447
2018
Q4
$3.29M Buy
278,111
+14,642
+6% +$173K ﹤0.01% 2482
2018
Q3
$3.79M Buy
263,469
+12,456
+5% +$179K ﹤0.01% 2537
2018
Q2
$3.74M Buy
251,013
+24,311
+11% +$362K ﹤0.01% 2504
2018
Q1
$2.96M Buy
226,702
+2,038
+0.9% +$26.6K ﹤0.01% 2548
2017
Q4
$2.83M Buy
224,664
+1,521
+0.7% +$19.2K ﹤0.01% 2555
2017
Q3
$2.89M Buy
223,143
+9,333
+4% +$121K ﹤0.01% 2535
2017
Q2
$3.18M Buy
213,810
+968
+0.5% +$14.4K ﹤0.01% 2456
2017
Q1
$2.55M Buy
212,842
+9,813
+5% +$118K ﹤0.01% 2517
2016
Q4
$2.8M Buy
203,029
+8,771
+5% +$121K ﹤0.01% 2435
2016
Q3
$2.6M Buy
194,258
+2,454
+1% +$32.9K ﹤0.01% 2394
2016
Q2
$2.06M Buy
191,804
+1,306
+0.7% +$14K ﹤0.01% 2459
2016
Q1
$2K Buy
190,498
+18,461
+11% +$194 ﹤0.01% 2462
2015
Q4
$2.04M Buy
172,037
+875
+0.5% +$10.4K ﹤0.01% 2469
2015
Q3
$2M Buy
171,162
+1,580
+0.9% +$18.4K ﹤0.01% 2443
2015
Q2
$2.45M Buy
169,582
+11,536
+7% +$166K ﹤0.01% 2371
2015
Q1
$2.2M Buy
158,046
+5,037
+3% +$70.2K ﹤0.01% 2377
2014
Q4
$2.11M Buy
153,009
+2,032
+1% +$28.1K ﹤0.01% 2391
2014
Q3
$1.85M Buy
150,977
+2,688
+2% +$32.9K ﹤0.01% 2406
2014
Q2
$1.85M Sell
148,289
-17,348
-10% -$217K ﹤0.01% 2414
2014
Q1
$1.85M Sell
165,637
-2,031
-1% -$22.7K ﹤0.01% 2385
2013
Q4
$2.03M Buy
167,668
+26,577
+19% +$322K ﹤0.01% 2279
2013
Q3
$1.72M Buy
141,091
+4,438
+3% +$54.1K ﹤0.01% 2254
2013
Q2
$1.81M Buy
+136,653
New +$1.81M ﹤0.01% 2107